Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device.
CarolinaEast Health System’s Heart Team is unveiling a minimally invasive therapy to treat people with atrial fibrillation (AFib) who are at risk of ischemic strokes.
North America to account for larger share in atrial fibrillation market during 2022–2028; growth driven by rising geriatric population, increasing occurrence of cardiovascular diseases, high accessibility to advanced technologies, growing development of innovative and technologically advanced products, and increasing healthcare expenditure